{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,11]],"date-time":"2026-08-11T20:29:47Z","timestamp":1786480187939,"version":"build-2736575974"},"reference-count":40,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"6","license":[{"start":{"date-parts":[[2026,1,23]],"date-time":"2026-01-23T00:00:00Z","timestamp":1769126400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":["Kidney360"],"published-print":{"date-parts":[[2026,6]]},"abstract":"<jats:sec>\n                    <jats:title>Key Points<\/jats:title>\n                    <jats:p>\n                      <jats:list list-type=\"bullet\">\n                        <jats:list-item>\n                          <jats:p>CKD was associated with higher odds of coronavirus disease 2019 death and hospitalization across all phases in Mexico.<\/jats:p>\n                        <\/jats:list-item>\n                        <jats:list-item>\n                          <jats:p>Patients with CKD had lower intensive care unit\/invasive mechanical ventilation use but higher in-intensive care unit fatality, especially at 18\u201364 years, which may reflect selection effects and triage decisions.<\/jats:p>\n                        <\/jats:list-item>\n                        <jats:list-item>\n                          <jats:p>Associations attenuated in 2022 but resurged by 2024; findings remained after municipal socioeconomic status adjustment.<\/jats:p>\n                        <\/jats:list-item>\n                      <\/jats:list>\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>CKD is among the strongest predictors of adverse coronavirus disease 2019 outcomes, yet how CKD-associated risk evolved across prevaccination, roll-out, mass-vaccination, and postpandemic phases remains incompletely defined in Latin America.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We performed a nationwide retrospective analysis of Mexico's historical surveillance open datasets, including all laboratory-confirmed cases from January 1, 2020, to June 30, 2025. The primary outcome was death among recorded cases (case fatality); secondary outcomes were hospitalization, intensive care unit (ICU) admission, and invasive mechanical ventilation (IMV). Multivariable logistic models were fit overall, by age strata and year\/pandemic phase, adjusting for demographics, comorbidities, and symptom-to-care interval; temporal patterns were summarized with locally estimated scatterplot smoothing and segmented interrupted time series analysis. Sensitivity analyses included models restricted to ICU admissions and models additionally adjusted for municipal socioeconomic context.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Among 7,359,354 cases, 70,144 (1.0%) had CKD; crude case fatality was 33% in CKD versus 4% without. In adjusted models, CKD was associated with higher case fatality (adjusted odds ratio [aOR], 1.20; 95% confidence interval [CI], 1.19 to 1.20) and hospitalization (aOR, 1.35; 95% CI, 1.35 to 1.35), but not with ICU admission (aOR, 0.98) or IMV (0.99). In the ICU-restricted cohort, CKD independently increased in-ICU case fatality (aOR, 1.38; 95% CI, 1.25 to 1.51), the strongest at age 18\u201364 years (aOR, 1.52) and smaller at \u226565 years (aOR, 1.19). Year-specific models showed attenuation during mass vaccination (2022 aOR, 1.13), followed by a resurgence in 2024 (aOR, 1.90). Locally estimated scatterplot smoothing\/interrupted time series revealed delayed and incomplete postvaccination benefit for CKD with trend acceleration in 2023. The findings were robust after adding municipal socioeconomic status indicators to adult models.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Across 5 years of nationwide surveillance, CKD remained a dominant, independent correlate of coronavirus disease 2019 case fatality and hospitalization, with risk resurging in 2024. Lower ICU\/IMV use yet higher in-ICU case fatality among patients with CKD may reflect selection effects and underscore the need for rapid escalation pathways.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.34067\/kid.0000001133","type":"journal-article","created":{"date-parts":[[2026,1,23]],"date-time":"2026-01-23T17:00:29Z","timestamp":1769187629000},"page":"1272-1284","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["Temporal Evolution of the Impact of CKD on COVID-19 Outcomes"],"prefix":"10.34067","volume":"7","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1977-5960","authenticated-orcid":false,"given":"Jos\u00e9 D.","family":"Gonz\u00e1lez-Barajas","sequence":"first","affiliation":[{"name":"Hospital Civil de Oriente, T\u00f3nala, Mexico"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manuel L.","family":"Prieto-Magallanes","sequence":"additional","affiliation":[{"name":"Hospital Civil de Oriente, T\u00f3nala, Mexico"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-7535-8070","authenticated-orcid":false,"given":"Carolina","family":"Romo-Alvarez","sequence":"additional","affiliation":[{"name":"Hospital Civil de Oriente, T\u00f3nala, Mexico"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0736-876X","authenticated-orcid":false,"given":"Bladimir","family":"D\u00edaz-Villavicencio","sequence":"additional","affiliation":[{"name":"Hospital Civil de Oriente, T\u00f3nala, Mexico"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Violeta A.","family":"Camarena-Arteaga","sequence":"additional","affiliation":[{"name":"Hospital Civil de Oriente, T\u00f3nala, Mexico"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana M.","family":"L\u00f3pez-Y\u00e1\u00f1ez","sequence":"additional","affiliation":[{"name":"Hospital Civil de Oriente, T\u00f3nala, Mexico"},{"name":"Centro Universitario de Tlajomulco, Universidad de Guadalajara, Tlajomulco de Z\u00fa\u00f1iga, Mexico"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Judith C.","family":"De Arcos-Jim\u00e9nez","sequence":"additional","affiliation":[{"name":"Hospital Civil de Oriente, T\u00f3nala, Mexico"},{"name":"Centro Universitario de Tlajomulco, Universidad de Guadalajara, Tlajomulco de Z\u00fa\u00f1iga, Mexico"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-1901-392X","authenticated-orcid":false,"given":"Jaime","family":"Briseno-Ramirez","sequence":"additional","affiliation":[{"name":"Hospital Civil de Oriente, T\u00f3nala, Mexico"},{"name":"Centro Universitario de Tlajomulco, Universidad de Guadalajara, Tlajomulco de Z\u00fa\u00f1iga, Mexico"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2026,1,23]]},"reference":[{"issue":"10334","key":"B1-20260625","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.1016\/S0140-6736(21)02796-3","article-title":"Estimating excess mortality due to the COVID-19 pandemic: a systematic analysis of COVID-19-related mortality, 2020-21","volume":"399","year":"2022","journal-title":"Lancet."},{"issue":"7942","key":"B2-20260625","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1038\/s41586-022-05522-2","article-title":"The WHO estimates of excess mortality associated with the COVID-19 pandemic","volume":"613","author":"Msemburi","year":"2023","journal-title":"Nature."},{"issue":"suppl 2","key":"B3-20260625","doi-asserted-by":"crossref","first-page":"ii2","DOI":"10.1093\/jac\/dkad311","article-title":"An overview of COVID-19 global epidemiology and discussion of potential drivers of variable global pandemic impacts","volume":"78","author":"Ashmore","year":"2023","journal-title":"J Antimicrob Chemother."},{"issue":"3","key":"B4-20260625","doi-asserted-by":"crossref","first-page":"e0247461","DOI":"10.1371\/journal.pone.0247461","article-title":"Population risk factors for severe disease and mortality in COVID-19: a global systematic review and meta-analysis","volume":"16","author":"Booth","year":"2021","journal-title":"PLoS One."},{"issue":"6","key":"B5-20260625","doi-asserted-by":"crossref","first-page":"e0270192","DOI":"10.1371\/journal.pone.0270192","article-title":"Clinical characteristics and risk factors for COVID-19 infection and disease severity: a nationwide observational study in Estonia","volume":"17","author":"Meister","year":"2022","journal-title":"PLoS One."},{"issue":"11","key":"B6-20260625","doi-asserted-by":"crossref","first-page":"e0241955","DOI":"10.1371\/journal.pone.0241955","article-title":"Prognostic factors for severity and mortality in patients infected with COVID-19: a systematic review","volume":"15","author":"Izcovich","year":"2020","journal-title":"PLoS One."},{"issue":"8","key":"B7-20260625","doi-asserted-by":"crossref","first-page":"e0237131","DOI":"10.1371\/journal.pone.0237131","article-title":"Impact of cardiovascular risk profile on COVID-19 outcome. A meta-analysis","volume":"15","author":"Sabatino","year":"2020","journal-title":"PLoS One."},{"issue":"10","key":"B8-20260625","doi-asserted-by":"crossref","first-page":"e0258154","DOI":"10.1371\/journal.pone.0258154","article-title":"Association of pre-existing comorbidities with mortality and disease severity among 167,500 individuals with COVID-19 in Canada: a population-based cohort study","volume":"16","author":"Ge","year":"2021","journal-title":"PLoS One."},{"issue":"8","key":"B9-20260625","doi-asserted-by":"crossref","first-page":"e0238215","DOI":"10.1371\/journal.pone.0238215","article-title":"Association of cardiovascular disease and 10 other pre-existing comorbidities with COVID-19 mortality: a systematic review and meta-analysis","volume":"15","author":"Ssentongo","year":"2020","journal-title":"PLoS One."},{"issue":"2","key":"B10-20260625","doi-asserted-by":"crossref","first-page":"e0246190","DOI":"10.1371\/journal.pone.0246190","article-title":"The prognostic value of comorbidity for the severity of COVID-19: a systematic review and meta-analysis study","volume":"16","author":"Fathi","year":"2021","journal-title":"PLoS One."},{"issue":"5","key":"B11-20260625","doi-asserted-by":"crossref","first-page":"2000547","DOI":"10.1183\/13993003.00547-2020","article-title":"Comorbidity and its impact on 1590 patients with COVID-19 in China: a nationwide analysis","volume":"55","author":"Guan","year":"2020","journal-title":"Eur Respir J."},{"issue":"15","key":"B12-20260625","doi-asserted-by":"crossref","first-page":"1938","DOI":"10.1016\/j.jacc.2021.02.017","article-title":"ACC health policy statement on cardiovascular disease considerations for COVID-19 vaccine prioritization: a report of the American college of Cardiology Solution Set Oversight Committee","volume":"77","author":"Driggin","year":"2021","journal-title":"J Am Coll Cardiol."},{"issue":"3","key":"B13-20260625","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1016\/j.kint.2022.05.015","article-title":"A retrospective cohort study predicting and validating impact of the COVID-19 pandemic in individuals with chronic kidney disease","volume":"102","author":"Dashtban","year":"2022","journal-title":"Kidney Int."},{"issue":"12","key":"B14-20260625","doi-asserted-by":"crossref","first-page":"2083","DOI":"10.1093\/ndt\/gfaa271","article-title":"Mortality analysis of COVID-19 infection in chronic kidney disease, haemodialysis and renal transplant patients compared with patients without kidney disease: a nationwide analysis from Turkey","volume":"35","author":"Ozturk","year":"2020","journal-title":"Nephrol Dial Transplant."},{"issue":"1","key":"B15-20260625","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1111\/joim.13239","article-title":"Increased vulnerability to COVID-19 in chronic kidney disease","volume":"290","author":"Carlson","year":"2021","journal-title":"J Intern Med."},{"issue":"1","key":"B16-20260625","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1093\/ndt\/gfaa314","article-title":"Chronic kidney disease is a key risk factor for severe COVID-19: a call to action by the ERA-EDTA","volume":"36","year":"2021","journal-title":"Nephrol Dial Transplant."},{"issue":"1","key":"B17-20260625","doi-asserted-by":"crossref","first-page":"2258","DOI":"10.1038\/s41598-022-06276-7","article-title":"Mortality and readmission rates among hospitalized COVID-19 patients with varying stages of chronic kidney disease: a multicenter retrospective cohort","volume":"12","author":"Appelman","year":"2022","journal-title":"Sci Rep."},{"issue":"2","key":"B18-20260625","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1053\/j.ajkd.2020.09.003","article-title":"Characteristics and outcomes of individuals with pre-existing kidney disease and COVID-19 admitted to intensive care units in the United States","volume":"77","author":"Flythe","year":"2021","journal-title":"Am J Kidney Dis."},{"issue":"1","key":"B19-20260625","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1186\/s12879-024-09414-w","article-title":"Prognostic significance of chronic kidney disease and impaired renal function in Japanese patients with COVID-19","volume":"24","author":"Tanaka","year":"2024","journal-title":"BMC Infect Dis."},{"issue":"22","key":"B20-20260625","doi-asserted-by":"crossref","first-page":"16078","DOI":"10.3390\/ijms242216078","article-title":"SCARF genes in COVID-19 and kidney disease: a path to comorbidity-specific therapies","volume":"24","author":"Carriazo","year":"2023","journal-title":"Int J Mol Sci."},{"issue":"1","key":"B21-20260625","doi-asserted-by":"crossref","first-page":"15205","DOI":"10.1038\/s41598-021-94570-1","article-title":"Clinical outcomes of hospitalized COVID-19 patients with renal injury: a multi-hospital observational study from Wuhan","volume":"11","author":"Chen","year":"2021","journal-title":"Sci Rep."},{"issue":"10","key":"B26-20260625","doi-asserted-by":"crossref","first-page":"e296","DOI":"10.1371\/journal.pmed.0040296","article-title":"The strengthening the reporting of observational studies in epidemiology (STROBE) statement: guidelines for reporting observational studies","volume":"4","author":"von Elm","year":"2007","journal-title":"PLoS Med."},{"key":"B27-20260625","first-page":"100624","article-title":"The evolving landscape of SARS-CoV-2 vaccination in Mexico: real-world evidence in Mexican pensioners","volume":"27","author":"Antonio-Villa","year":"2023","journal-title":"Lancet Reg Health Am."},{"issue":"4, jul-ago","key":"B28-20260625","doi-asserted-by":"crossref","first-page":"381","DOI":"10.21149\/16145","article-title":"Vacunaci\u00f3n en personas adultas y adultas mayores en M\u00e9xico","volume":"66","author":"Mongua-Rodr\u00edguez","year":"2024","journal-title":"Salud Publica Mex."},{"key":"B29-20260625","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1016\/j.ijid.2023.01.040","article-title":"Effectiveness of a nationwide COVID-19 vaccination program in Mexico against symptomatic COVID-19, hospitalizations, and death: a retrospective analysis of national surveillance data","volume":"129","author":"Bello-Chavolla","year":"2023","journal-title":"Int J Infect Dis."},{"issue":"5","key":"B31-20260625","doi-asserted-by":"crossref","first-page":"e0284130","DOI":"10.1371\/journal.pone.0284130","article-title":"Waning vaccine response to severe COVID-19 outcomes during omicron predominance in Thailand","volume":"18","author":"Intawong","year":"2023","journal-title":"PLoS One."},{"issue":"12","key":"B32-20260625","doi-asserted-by":"crossref","first-page":"1573","DOI":"10.1016\/j.cmi.2023.08.007","article-title":"Waning protection after vaccination and prior infection against COVID-19-related mortality over 18 months","volume":"29","author":"Dietler","year":"2023","journal-title":"Clin Microbiol Infect."},{"key":"B33-20260625","doi-asserted-by":"crossref","first-page":"126966","DOI":"10.1016\/j.vaccine.2025.126966","article-title":"Durability of COVID-19 vaccine and infection induced immunity: a systematic review and meta-regression analysis","volume":"54","author":"Moore","year":"2025","journal-title":"Vaccine."},{"issue":"7","key":"B34-20260625","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.34067\/KID.0006852020","article-title":"Outcomes among hospitalized chronic kidney disease patients with COVID-19","volume":"2","author":"Khatri","year":"2021","journal-title":"Kidney360."},{"issue":"5","key":"B35-20260625","doi-asserted-by":"crossref","first-page":"e0268050","DOI":"10.1371\/journal.pone.0268050","article-title":"Associations of vaccine status with characteristics and outcomes of hospitalized severe COVID-19 patients in the booster era","volume":"17","author":"Freund","year":"2022","journal-title":"PLoS One."},{"issue":"1","key":"B36-20260625","doi-asserted-by":"crossref","first-page":"24978","DOI":"10.1038\/s41598-025-98788-1","article-title":"Interplay of kidney function and anti-SARS-CoV-2 antibodies in COVID-19 mortality: a prospective cohort study","volume":"15","author":"Mink","year":"2025","journal-title":"Sci Rep."},{"issue":"21","key":"B37-20260625","doi-asserted-by":"crossref","first-page":"14074","DOI":"10.3390\/ijerph192114074","article-title":"Mortality risk factors for coronavirus infection in hospitalized adults in Brazil: a retrospective cohort study","volume":"19","author":"Guimar\u00e3es","year":"2022","journal-title":"Int J Environ Res Public Health."},{"issue":"5","key":"B38-20260625","doi-asserted-by":"crossref","first-page":"151318","DOI":"10.1016\/j.semnephrol.2023.151318","article-title":"COVID-19 and kidney disease: progress in health inequity from low-income settings","volume":"42","author":"Tannor","year":"2022","journal-title":"Semin Nephrol."},{"issue":"10S","key":"B39-20260625","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1681\/ASN.20213210S1777c","article-title":"ICU admission during the COVID-19 pandemic in overwhelmed institutions: is CKD a significant risk factor for consideration in ICU admission?","volume":"32","author":"Zavala","year":"2021","journal-title":"J Am Soc Nephrol."},{"key":"B40-20260625","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1007\/978-3-030-71697-4_8","article-title":"SARS-CoV-2 infection and the kidneys: an evolving picture","volume":"1327","author":"George","year":"2021","journal-title":"Adv Exp Med Biol."},{"issue":"6","key":"B41-20260625","doi-asserted-by":"crossref","first-page":"767","DOI":"10.2215\/CJN.04460422","article-title":"COVID-19 vaccination for patients undergoing long-term hemodialysis","volume":"17","author":"Korst","year":"2022","journal-title":"Clin J Am Soc Nephrol."},{"key":"B42-20260625","doi-asserted-by":"crossref","first-page":"961642","DOI":"10.3389\/fimmu.2023.961642","article-title":"Identification of common molecular signatures of SARS-CoV-2 infection and its influence on acute kidney injury and chronic kidney disease","volume":"14","author":"Zhang","year":"2023","journal-title":"Front Immunol."},{"key":"B43-20260625","doi-asserted-by":"crossref","first-page":"1376654","DOI":"10.3389\/fimmu.2024.1376654","article-title":"Immunologic and inflammatory consequences of SARS-CoV-2 infection and its implications in renal disease","volume":"15","author":"Naiditch","year":"2024","journal-title":"Front Immunol."},{"issue":"1","key":"B44-20260625","doi-asserted-by":"crossref","first-page":"e0261764","DOI":"10.1371\/journal.pone.0261764","article-title":"Latin American registry of renal involvement in COVID-19 disease. The relevance of assessing proteinuria throughout the clinical course","volume":"17","author":"Lombardi","year":"2022","journal-title":"PLoS One."},{"issue":"5","key":"B45-20260625","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1016\/j.kint.2020.03.005","article-title":"Kidney disease is associated with in-hospital death of patients with COVID-19","volume":"97","author":"Cheng","year":"2020","journal-title":"Kidney Int."}],"container-title":["Kidney360"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.34067\/KID.0000001133","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,11]],"date-time":"2026-08-11T19:56:25Z","timestamp":1786478185000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.34067\/KID.0000001133"}},"subtitle":["A 5-Year Nationwide Analysis"],"short-title":[],"issued":{"date-parts":[[2026,1,23]]},"references-count":40,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.34067\/kid.0000001133","relation":{},"ISSN":["2641-7650"],"issn-type":[{"value":"2641-7650","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,23]]},"assertion":[{"value":"2025-07-14","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-01-16","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}